CHILDREN'S COLDCALM PELLETS OTC
Generic Name and Formulations:
Allium cepa 3C HPUS, Apis mellifica 6C HPUS, Belladonna 6C HPUS, Eupatorium perfoliatum 3C HPUS, Gelsemium sempervirens 6C HPUS, Kali bichromicum 6C HPUS, Nux vomica 3C HPUS, Phytolacca decandra 6C HPUS, Pulsatilla 6C HPUS; pellets.
Indications for CHILDREN'S COLDCALM PELLETS:
Temporary relief of cold symptoms, such as sneezing, runny nose, nasal congestion, minor sore throat.
<3yrs: not recommended. ≥3yrs: Dissolve pellets in the mouth. 5 pellets every 20 minutes for 1 hour, then 5 pellets every 2 hours until symptoms are relieved.
Pregnancy. Nursing mothers.
Pellets—160 (80 pellets/tube)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC